Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.
Pseudoexfoliative Glaucoma: early-phase trial registry
A small indexed set (3 trials) with no open enrollment listed right now.
Corpus placement: #5,209 of 28,707 conditions by registered trial count.
3 US clinical trials · none currently recruiting · #5,209 of 28,707 conditions by registered trial count
Pseudoexfoliative Glaucoma: 3 US clinical trials tracked, none currently recruiting.
Pseudoexfoliative Glaucoma is the subject of 3 registered US clinical trials on ClinicalTrials.gov, none currently recruiting. 0 are in Phase 3-4 (later-stage) and 1 in Phase 1-2 (earlier-stage). The most active sponsor is Ivantis, running 1 of these trials.
Enrollment posture brief
Registry condition pseudoexfoliative-glaucoma
OPEN 0 | RECR 0% | LATE 0 | EARLY 1 | RANK #5209 | SPON 1
Volume-matched condition peers
Nearest open-share peer: Accelerated Phase Chronic Myelogenous Leukemia (0% recruiting · 12 trials)
Pseudoexfoliative Glaucoma has no open enrollment in this registry pull (3 archived studies). Peers show how other volume-matched labels compare on open share. How peer matching works →
Key findings
What ClinicalTrials.gov does not surface for Pseudoexfoliative Glaucoma on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.
-
Pseudoexfoliative Glaucoma is recruiting below its size-band peers.
0 of 3 indexed trials (0%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.
Indexed trials (enrollment closed)
3 total, page 1 of 1
Advanced Glaucoma Progression Study
University of California, Los Angeles
NCT01742819
Dose-Finding Study Comparing the Safety and Efficacy of Latanoprost to a Novel Treatment for Glaucoma
Bausch & Lomb Incorporated
NCT00441883
Comparing Effectiveness of the Hydrus Microstent (TM) to Two iStents to Lower IOP in Phakic Eyes
Ivantis
NCT02023242
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 2 | 1 |
Top Sponsors
Named interventions
Most-linked intervention names on Pseudoexfoliative Glaucoma records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.
US sites by state
Facility locations filed on Pseudoexfoliative Glaucoma trials. A trial with sites in several states counts in each.
Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.
Related
What to do with this Pseudoexfoliative Glaucoma page
3 registered trials, 0 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.
- No Pseudoexfoliative Glaucoma trials are currently recruiting in this registry; that can change as new trials post, or check the broader research index. Browse research indexes
- Ivantis sponsors the most Pseudoexfoliative Glaucoma trials on record, review their full trial history before evaluating a specific study. See Ivantis's trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Pseudoexfoliative Glaucoma condition card totals 3 registered trials; most-linked intervention iStent Trabecular Micro Bypass; top US site state California. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.